SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUM.L Regulatory News (NUM)

  • There is currently no data for NUM

Trading Update

30 Sep 2021 07:00

RNS Number : 4571N
Numis Corporation PLC
30 September 2021
 

Numis Corporation Plc ("Numis")

Trading Update

30 September 2021

 

Thursday, 30 September 2021 at 7.00am: Numis Corporation Plc ("Numis") is today issuing a trading update in respect of the year ending 30 September 2021.

Numis maintained its positive momentum and delivered a strong performance in the final quarter of the financial year. Whilst there was an anticipated pause in IPO activity and more subdued markets in general over the summer period, this was offset by the completion of a number of significant M&A transactions involving Numis in a lead advisory capacity. Revenue for the second half will exceed the level achieved in the second half of FY20 which featured a significant volume of COVID related capital markets transactions. Full year revenue is expected to be in the region of £215m (FY20: £154.9m), with the benefit of operational gearing leading to profits significantly higher than the prior year (FY20 PBT: £37.1m).

Investment Banking revenues have grown significantly and will be in excess of £150m for the year (FY20: £101.7m). Alongside market share gains in our core UK capital markets business, we have seen material revenue contributions from M&A and private markets transactions. In addition we are increasingly able to leverage our UK track record and reputation in new markets. As a result, in the past year we have acted on a number of capital markets transactions, both public and private, for non-UK issuers, most notably in the digital consumer and fintech sectors. During the second half we continued to selectively invest in talent, to both increase the capacity of the Investment Banking platform and broaden our capabilities.

Equities delivered a strong second half performance, although lower than the exceptional performance achieved in the first half. Given the favourable market backdrop we increased the capital allocated to our trading books and delivered good, and consistent, trading profits throughout year. Institutional income is ahead of the prior year underpinned by resilient research payments, market share gains and good activity levels in UK equities. 

Our pipeline remains very strong, and the wider market outlook for Numis is positive. We expect to launch a number of IPOs in the coming weeks, the capital raising environment is active across both public and private markets, and UK M&A is likely to remain at elevated levels as we emerge from the pandemic. Our strategy to build a more diversified, yet agile, investment banking business has contributed to an excellent year for Numis. We have recently completed the move to our new headquarters at 45 Gresham Street and we look forward to continuing on our strategic path supported by our exceptional colleagues.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014

 

 

Contacts

Numis:

Noreen Biddle-Shah, Head of Corporate Communications 020 7260 1441 

 

Brunswick:

Nick Cosgrove 020 7404 5959

Simone Selzer 020 7404 5959

 

Grant Thornton UK LLP (Nominated Adviser):Philip Secrett 020 7728 2578

Harrison Clarke 020 7184 4384

Lukas Girzadas 020 7865 2850

 

Notes for Editors

Numis is a leading independent investment banking group offering a full range of research, execution, corporate broking and advisory services to companies and their investors. Numis is listed on AIM, and has offices in London and New York.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUKAWRABUKUAR
Date   Source Headline
28th Mar 20223:59 pmRNSTransaction in Own Shares & Total Voting Rights
24th Mar 20223:48 pmRNSTransaction in Own Shares & Total Voting Rights
22nd Mar 20224:09 pmRNSTransaction in Own Shares & Total Voting Rights
18th Mar 20223:43 pmRNSTransaction in Own Shares & Total Voting Rights
18th Mar 202210:18 amRNSNotification of Major Holdings
17th Mar 20229:31 amRNSTransaction in Own Shares & Total Voting Rights
11th Mar 20223:36 pmRNSTransaction in Own Shares & Total Voting Rights
7th Mar 20224:47 pmRNSTransaction in Own Shares & Total Voting Rights
28th Feb 20225:02 pmRNSTransaction in Own Shares & Total Voting Rights
24th Feb 20227:00 amRNSBoard Change – Appointment of Independent NED
22nd Feb 20222:35 pmRNSTransaction in Own Shares & Total Voting Rights
10th Feb 202210:03 amRNSTransaction in Own Shares and Total Voting Rights
8th Feb 20221:13 pmRNSBoard Change
8th Feb 20221:12 pmRNS2022 Annual General Meeting ('AGM')
8th Feb 20227:00 amRNSAGM Trading Statement
7th Feb 20229:39 amRNSTransaction in Own Shares and Total Voting Rights
4th Feb 20224:14 pmRNSHolding(s) in Company
1st Feb 20224:38 pmRNSTransaction in Own Shares and Total Voting Rights
21st Jan 20224:00 pmRNSTransaction in Own Shares and Total Voting Rights
21st Jan 20221:00 pmRNSDirectors’ Dealing
19th Jan 20227:00 amRNSGrant of awards under 2021 LTIP
14th Jan 20223:53 pmRNSTransaction in Own Shares and Total Voting Rights
10th Jan 20224:27 pmRNSTransaction in Own Shares and Total Voting RIghts
5th Jan 20227:00 amRNSAppointment of General Counsel & Company Secretary
4th Jan 20223:21 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Dec 20214:53 pmRNSTransaction in Own Shares and Total Voting Rights
22nd Dec 20214:33 pmRNSTransaction in Own Shares and Total Voting Rights
21st Dec 20215:04 pmRNSTransaction in Own Shares and Total Voting Rights
20th Dec 20212:30 pmRNSAnnual Report and AGM Notice
20th Dec 202112:29 pmRNSReplacement Director's Dealing
20th Dec 202112:09 pmRNSHolding(s) in Company
17th Dec 202112:31 pmRNSDirector’s Dealing
15th Dec 20217:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Dec 20217:00 amRNSFull Year Results for the year ended 30 Sep 2021
29th Nov 20214:58 pmRNSNotice of Final Results for the year ended 30 Sep
18th Nov 20214:03 pmRNSHolding(s) in Company
30th Sep 202112:32 pmRNSTotal Voting Rights
30th Sep 20217:00 amRNSTrading Update
17th Sep 20214:25 pmRNSTR-1: Notification of major holdings
13th Sep 20216:29 pmRNSTR-1: Notification of major holdings
13th Sep 20216:27 pmRNSTR-1: Notification of major holdings
13th Sep 202112:54 pmRNSTR-1: Notification of major holdings
13th Sep 202112:50 pmRNSTR-1: Notification of major holdings
1st Sep 20217:00 amRNSChange of Registered Office
10th Aug 20217:00 amRNSBoard Change
29th Jul 20216:07 pmRNSTR-1: Notification of major holdings
14th Jul 20217:00 amRNSTrading Update
14th May 20217:00 amEQSEdison Investment Research Limited: Numis Corporation (NUM): Very strong results, consistent strategy
7th May 20217:00 amRNSHalf Year Results
23rd Apr 20214:24 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.